R&D Precision medicine - closing the loop: What happens after th... We often talk about diagnostics as the gateway to precision medicine. But what happens before and after the test?
Sales & Marketing Sponsored Company Profile: Aktiia Hypertension is known to be one of the most prevalent chronic health conditions globally.
News Heart disease risk ‘calculator’ could save lives UK researchers say they have developed an algorithm that is more accurate than current tools at predicting an individual’s risk of developing cardiovascular disease in the
R&D The race for obesity drug assets heats up The existing treatments for weight loss have drawn interest from across the industry, as their efficacy and sales potential become evident.
Market Access Nine for 2024, Pt 1: From fragility to resilience This year was a year of significant new beginnings for pharma and healthcare, yet, it was still impacted by the long-term fallouts of the pandemic.
Patients The paradox of cardiovascular disease: Out in the open, but ... When prompted with the question, ’What is the world’s deadliest disease?’, what would be your first guess?
News Appeal finds NICE must reconsider Alzheimer's drugs Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
